Sustained community transmission among largely unvaccinated populations continues to drive elevated U.S. measles incidence, with the CDC reporting 2,371 confirmed cases through July 30, 2026—already exceeding the 2025 full-year total of 2,289. Most cases (94%) are outbreak-associated, concentrated in jurisdictions with low MMR coverage, while importation events remain limited. Official surveillance data reflect confirmed reports only, with potential undercounting due to variable state-level detection. Key variables for August accumulation include ongoing outbreak containment, seasonal travel patterns, and any shifts in vaccination uptake or public health interventions ahead of CDC's weekly updates. Historical precedent shows rapid case growth possible in under-immunized clusters before resolution thresholds are assessed.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วMeasles cases in U.S. by August 31?
Measles cases in U.S. by August 31?
ใหม่
Aug 31, 2026
2400+
98%
2450+
93%
2500+
83%
2550+
66%
2600+
56%
$637 ปริมาณ
2400+
$472 ปริมาณ
98%
2450+
$125 ปริมาณ
93%
2500+
$0 ปริมาณ
83%
2550+
$29 ปริมาณ
66%
2600+
$10 ปริมาณ
56%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission among largely unvaccinated populations continues to drive elevated U.S. measles incidence, with the CDC reporting 2,371 confirmed cases through July 30, 2026—already exceeding the 2025 full-year total of 2,289. Most cases (94%) are outbreak-associated, concentrated in jurisdictions with low MMR coverage, while importation events remain limited. Official surveillance data reflect confirmed reports only, with potential undercounting due to variable state-level detection. Key variables for August accumulation include ongoing outbreak containment, seasonal travel patterns, and any shifts in vaccination uptake or public health interventions ahead of CDC's weekly updates. Historical precedent shows rapid case growth possible in under-immunized clusters before resolution thresholds are assessed.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Jul 31, 2026, 10:25 AM ET
ปริมาณการซื้อขาย
$637วันสิ้นสุด
Aug 31, 2026ตลาดเปิดเมื่อ
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission among largely unvaccinated populations continues to drive elevated U.S. measles incidence, with the CDC reporting 2,371 confirmed cases through July 30, 2026—already exceeding the 2025 full-year total of 2,289. Most cases (94%) are outbreak-associated, concentrated in jurisdictions with low MMR coverage, while importation events remain limited. Official surveillance data reflect confirmed reports only, with potential undercounting due to variable state-level detection. Key variables for August accumulation include ongoing outbreak containment, seasonal travel patterns, and any shifts in vaccination uptake or public health interventions ahead of CDC's weekly updates. Historical precedent shows rapid case growth possible in under-immunized clusters before resolution thresholds are assessed.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$637วันสิ้นสุด
Aug 31, 2026ตลาดเปิดเมื่อ
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Sustained community transmission among largely unvaccinated populations continues to drive elevated U.S. measles incidence, with the CDC reporting 2,371 confirmed cases through July 30, 2026—already exceeding the 2025 full-year total of 2,289. Most cases (94%) are outbreak-associated, concentrated in jurisdictions with low MMR coverage, while importation events remain limited. Official surveillance data reflect confirmed reports only, with potential undercounting due to variable state-level detection. Key variables for August accumulation include ongoing outbreak containment, seasonal travel patterns, and any shifts in vaccination uptake or public health interventions ahead of CDC's weekly updates. Historical precedent shows rapid case growth possible in under-immunized clusters before resolution thresholds are assessed.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย